Subscribe to Pharmaceutical Processing News

The Lead

Pfizer Beats Wall Street Third Quarter Forecasts

October 28, 2014 | Comments

On a per-share basis, the New York-based company said it had profit of 42 cents. Earnings, adjusted for non-recurring costs and to account for discontinued operations, were 57 cents per share.          


Defense Secretary Hagel Approves 21-Day Ebola Quarantine for Troops

October 29, 2014 2:35 pm | by ROBERT BURNS, AP National Security Writer | Comments

All American troops returning from Ebola response missions in West Africa will be placed in supervised isolation for 21 days, Defense Secretary Chuck Hagel said Wednesday. He called it a "safety valve" sought by military members' families.  


EMA Advises on Development Plan for GSK Ebola Vaccine

October 29, 2014 11:15 am | Comments

The European Medicines Agency (EMA) has given scientific advice to GSK on its development plan for an Ebola vaccine. This is the first time in the current Ebola outbreak that EMA has given ‘rapid scientific advice’ using an accelerated procedure.


GlobalData Analyst: Lack of Suitable Resources Limiting Ebola Diagnoses in West Africa

October 29, 2014 10:57 am | Comments

Poor logistics and low trained staff numbers are two of the greatest limitations to providing a sufficient molecular diagnostic capacity for Ebola in West Africa, where only 56% of cases are described as confirmed and the remaining cases are probable or suspected, according to an analyst with research and consulting firm GlobalData.


Where's the Czar? Ebola Raises Management Questions

October 29, 2014 9:15 am | by JIM KUHNHENN, Associated Press | Comments

President Barack Obama's commander in the fight against Ebola was expected to operate below the public radar. But did that mean invisible? Ron Klain has barely been seen, and a week before midterm elections, Obama is pressing to dispel criticism that the government can't manage the Ebola crisis.


Nurse: I'll Go to Court if Maine Quarantines Me

October 29, 2014 8:49 am | Comments

A nurse who was confined against her will at a New Jersey hospital after returning from West Africa where she treated Ebola patients said Wednesday that she's prepared to go to court if the state of Maine tries to quarantine her.    


North Dakota Court Bans Use of Drug in Abortions

October 29, 2014 8:44 am | by JAMES MacPHERSON, Associated Press | Comments

The North Dakota Supreme Court on Tuesday upheld a state law that limits the use of drugs to perform abortions, a move abortion-rights supporters say will end the use of medications to perform the procedure.       


Politics of Ebola Tricky for Christie, Cuomo

October 29, 2014 8:33 am | by JONATHAN LEMIRE, Associated Press; JILL COLVIN, Associated Press | Comments

Two ambitious governors — one Republican, one Democrat — known for their no-nonsense, take-charge style in a calamity have set off a furor with their aggressive handling of the Ebola crisis, and how it plays out could shape their political futures.


Vertex' Losses Less Than Wall Street Third Quarter Forecasts

October 29, 2014 8:29 am | Comments

Vertex Pharmaceuticals on Tuesday reported a loss of $170.1 million in its third quarter. On a per-share basis, the Boston-based company said it had a loss of 72 cents. The results surpassed Wall Street expectations.     


States Ask Congress to Intervene on Drug Prices

October 29, 2014 8:24 am | Comments

In a letter Tuesday to key congressional committees, the National Association of Medicaid Directors said lawmakers should consider everything from outright price controls on manufacturers to federal help for states trying to pay for the new medications.


Boehringer Ingelheim and Lilly Revising Operational Structure of Diabetes Alliance

October 29, 2014 8:19 am | Comments

In a move that will strengthen their alliance by enhancing efficiencies and enabling greater focus on product launches, Boehringer Ingelheim and Eli Lilly and Company are changing the operational and financial structure of their diabetes alliance in certain countries.


Alnylam Appoints New Senior Vice President, Clinical Development

October 29, 2014 8:12 am | Comments

Alnylam Pharmaceuticals has announced the appointment of Pushkal Garg, M.D., to the position of Senior Vice President, Clinical Development. At Alnylam, he will join the existing development team and be responsible for managing the company’s clinical research, clinical operations, and biometrics functions.


Sanofi Ousts CEO Amid Pressure Over Diabetes Drug

October 29, 2014 8:08 am | by GREG KELLER, Associated Press | Comments

Sanofi sacked its CEO Wednesday following a board room rift over the handling of one of France's largest publicly traded companies. Christopher Viehbacher, the first non-Frenchman to lead Sanofi, was dismissed after six years running the company that traces its roots to the early 19th century.


Metrics Scientist Awarded Patent For Zero-Order Release Tablet Technology

October 28, 2014 1:35 pm | Comments

An expert scientist in pharmaceutical formulation development at Metrics Contract Services has been awarded a patent for intellectual property about controlled release technology.            


INTERPHEX Launches New Website; Registration Open For 2015

October 28, 2014 1:16 pm | Comments

International Pharmaceutical Expo (INTERPHEX), sponsored by Parenteral Drug Association (PDA), is the premier annual industry event dedicated to showcasing pharmaceutical and biopharmaceutical innovation, technology and knowledge. In our ongoing effort to enhance user experience, INTERPHEX is proud to announce the launch of its newly redesigned website,


Catalent Appoints New Asia Pacific President

October 28, 2014 9:10 am | Comments

Catalent today announced the promotion of Australia Country General Manager, Mark Bisset, to President, Catalent Asia Pacific. He succeeds David Heyens who has announced that he plans to retire from Catalent on December 31st 2014.    



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.